Home				Neurodegenerative Diseases Tx/Dx CI - Y2006 week 43
DATE	SOURCE	OTHER PARTY INVOLVED	INDICATION(S)	HEADLINES - CLICK TO VIEW FULL RELEASE
10/26/06	NeoStem (US)		Multiple sclerosis	NeoStem, Inc. Appoints Julio C. Guerra, MD, ABP, as Director of Sales and Marketing
10/25/06	CoLucid Pharmaceuticals (US)		Alzheimer	CoLucid Names James F. White as President and Chief Executive Officer
10/24/06	MultiCell Technologies (US)		Multiple sclerosis	MultiCell Establishes Clinical Development Team to Lead UK Phase IIb Human Clinical Trials for MCT-125 for the Treatment of Fatigue in MS Patients
10/24/06	Targacept (US)		Alzheimer	Targacept Announces Addition of Alan W. Dunton, M.D. to Its Board of Directors
10/23/06	Athenagen (US)		Alzheimer	Athenagen Expands Leadership Team With Two Seasoned Drug Development Professionals